Fundamental ferroptosis-related intracellular pathways and mitochondrial regulation
The fundamental ferroptosis-related intracellular pathways and mitochondrial regulation. Metabolic pathways for lipids: Xc mediates the exchange of cystine and Glu, while cystine stimulates GSH synthesis. Gln is converted to Glu, which is crucial for CDI ferroptosis, with the assistance of GIS2 and the action of GPT and GDT. ACSL4 and LPCAT 3 esterify PUFA to PE, preparing for subsequent peroxidation reactions catalyzed by LOX or POR enzymes or mediated by cellular free iron via the Fenton reaction. Iron metabolic pathway: Iron binds to TF, enters the cell via TfR1, and is then released into the LIP in the cytoplasm, where it participates in the Fenton reaction, producing ROS and promoting ferroptosis. ROS can also trigger the secretion of IL-1 and IL-18 via inflammasome signaling, contributing to inflammation. ETC stimulates ATP synthesis via PCr and activates AMPK, which inhibits ACC and decreases PUFA synthesis. Iron can enter the mitochondria through VDAC2/3, Mfrn1/2 or via the Fenton reaction, resulting in ferroptosis. Mitochondrial iron can also enter the ISC assembly machinery, which is responsible for the maturation of all cellular (Fe-S) clusters. NEET iron-sulfur proteins transfer their 2Fe-2S clusters to the apolipoprotein receptor proteins and the CIA system. FtMt is involved in mitochondrial iron storage. BID induces ferroptosis by activating BAX and BAK And CISD1 modulates iron export in mitochondria. Abbreviations: AOA, amino-oxyacetic acid; ACSF2, acyl-CoA synthetase family member 2; Glu, glutamate; Gln, glutamine; AMPK, Adenosine monophosphate-activated protein kinase; GSSG, glutathione disulfide; GSH, glutathione; PUFA, polyunsaturated fatty acid; GPT, glutamate-pyruvate transaminase; ACSL4, acyl-CoA synthetase long-chain family member 4; TfR1, transferrin Receptor 1; GLS2, glutaminase 2; Mfrn1/2, mitoferrin 1/2; mitoROS, mitochondrial ROS; LIP, labile iron pool; BID, BH3 interacting-domain death agonist; BAK, Bcl-2 homologous antagonist killer; VDAC2/3, voltage-dependent anion channels 2/3; BAX, Bcl-2-associated X protein; ETC, electron transport chain; CISD1, CDGSH Iron Sulfur Domain 1; FtMt, mitochondrial ferritin; ACSL4, acyl-CoA synthetase long-chain family member 4; MCU, mitochondrial calcium uniporter; LOX, lipoxygenase; CoA, coenzyme A; α-KG: alpha-ketoglutarate; GDH, glutamate dehydrogenase; GOT, glutamic oxaloacetic transaminase; TCA cycle, tricarboxylic acid cycle; PCr, phosphocreatine; ATP, adenosine triphosphate; ROS, ROS; IL-1β, Interleukin-1β; 12/15LOX, 12/15 lipoxygenase; FPN, ferroportin; IL-18, Interleukin-18; ACC, acetyl-CoA carboxylase; MNCX, mitochondrial sodium calcium exchanger
Publication
Mitochondria-mediated Ferroptosis in Diseases Therapy: From Molecular Mechanisms to Implications (2024) Fuhai Feng, et al. Aging Dis. 2024 Apr 1;15(2). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | GPX4 | GPX4 | ncbigene_symbol | GPX4 | 2879 |
| Homo sapiens | Primates | FPN | FPN | ncbigene_synonym | SLC40A1 | 30061 |
| Homo sapiens | Primates | LIP | LIP | ncbigene_synonym | SMG1 | 23049 |
| Homo sapiens | Primates | LOX | LOX | ncbigene_symbol | LOX | 4015 |
| Homo sapiens | Primates | ACSL4 | ACSL4 | ncbigene_symbol | ACSL4 | 2182 |
| Homo sapiens | Primates | NAD(P)H | NADPH | ncbigene_synonym | DECR1 | 1666 |
| Homo sapiens | Primates | Mfm1/2 | MFM2 | ncbigene_synonym | CRYAB | 1410 |
| Homo sapiens | Primates | PUFA | PUFA | ncbigene_synonym | PUM3 | 9933 |
| Homo sapiens | Primates | VDAC2/3 | VDAC3 | ncbigene_symbol | VDAC3 | 7419 |
| Homo sapiens | Primates | VDAC2/3 | VDAC3 | ncbigene_synonym | VDAC1P5 | 10187 |
| Homo sapiens | Primates | VDAC2/3 | VDAC2 | ncbigene_symbol | VDAC2 | 7417 |
| Homo sapiens | Primates | GLS2 | GLS2 | ncbigene_symbol | GLS2 | 27165 |
| Homo sapiens | Primates | GOT | GOT | famplex_relations | GOT1 | 2805 |
| Homo sapiens | Primates | GOT | GOT | famplex_relations | GOT2 | 2806 |
| Homo sapiens | Primates | GPT | GPT | ncbigene_symbol | GPT | 2875 |
| Homo sapiens | Primates | GPT | GPT | ncbigene_synonym | DPAGT1 | 1798 |
| Homo sapiens | Primates | ACC | ACC | ncbigene_synonym | ACACA | 31 |
| Homo sapiens | Primates | ACC | ACC | ncbigene_synonym | BMS1 | 9790 |
| Homo sapiens | Primates | ACC | ACC | famplex_relations | ACACB | 32 |
| Homo sapiens | Primates | TAC | TAC | famplex_relations | TAC1 | 6863 |
| Homo sapiens | Primates | TAC | TAC | famplex_relations | TAC3 | 6866 |
| Homo sapiens | Primates | TAC | TAC | famplex_relations | TAC4 | 255061 |
| Homo sapiens | Primates | AMPK+ | AMPK | ncbigene_synonym | PRKAA1 | 5562 |
| Homo sapiens | Primates | AMPK+ | AMPK | ncbigene_synonym | PRKAA2 | 5563 |
| Homo sapiens | Primates | AMPK+ | AMPK | ncbigene_synonym | PRKAB1 | 5564 |
| Homo sapiens | Primates | AMPK+ | AMPK | famplex_relations | PRKAB2 | 5565 |
| Homo sapiens | Primates | AMPK+ | AMPK | famplex_relations | PRKAG1 | 5571 |
| Homo sapiens | Primates | AMPK+ | AMPK | famplex_relations | PRKAG2 | 51422 |
| Homo sapiens | Primates | AMPK+ | AMPK | famplex_relations | PRKAG3 | 53632 |
| Homo sapiens | Primates | ATP | ATP | ncbigene_synonym | ATP8A2 | 51761 |
| Homo sapiens | Primates | BAK | BAK | ncbigene_synonym | BAK1 | 578 |
| Homo sapiens | Primates | VDAC | VDAC | famplex_relations | VDAC1 | 7416 |
| Homo sapiens | Primates | BID | BID | ncbigene_symbol | BID | 637 |
| Homo sapiens | Primates | 15LOX | 15LOX | ncbigene_synonym | ALOX15 | 246 |
| Homo sapiens | Primates | IL-18 | IL-18 | ncbigene_synonym | IL18 | 3606 |
| Homo sapiens | Primates | IL-1ẞ | IL1 | ncbigene_synonym | IL1A | 3552 |
| Homo sapiens | Primates | IL-1ẞ | IL1 | ncbigene_synonym | IL1B | 3553 |
| Homo sapiens | Primates | CIA | CIA | ncbigene_synonym | ASF1A | 25842 |
| Homo sapiens | Primates | CIA | CIA | ncbigene_synonym | NCOA5 | 57727 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Cysteine | cysteine | cysteine | chebi:15356 | |
| GSH | GSH | L-gamma-glutamyl-L-cysteinylglycine | chebi:16856 | |
| Glu | Glu | 2-aminopentanedioic acid | chebi:18237 | |
| GSSG | GSSG | (2S,2'S)-5,5'-[disulfanediylbis({(2R)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid) | chebi:17858 | |
| iron | iron | Fe | chebi:18248 | |
| calcium | calcium | Ca | chebi:22984 | |
| Gln | Gln | L-glutamine residue | chebi:30011 | |
| Fatty acid | Fatty acid | fatty acids | chebi:35366 | |
| PUFA | PUFA | chebi:76567 | ||
| Gln | Gln | L-glutamine residue | chebi:30011 | |
| Glu | Glu | 2-aminopentanedioic acid | chebi:18237 | |
| Acetyl-CoA | acetyl-CoA | 3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate) | chebi:57288 | |
| Acetyl-CoA | acetyl-CoA | 3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate) | chebi:57288 | |
| ACC | ACC | 1-aminocyclopropane-1-carboxylate | chebi:30526 | |
| ACC | ACC | 1-aminocyclopropane-1-carboxylate | chebi:30526 | |
| OAA | OAA | chebi:132560 | ||
| TAC | TAC | chebi:53498 | ||
| L-Malate | L-malate | (2S)-2-hydroxybutanedioate | chebi:15589 | |
| ATP | ATP | ATP | chebi:30616 | |
| Fumarate | fumarate | fumarate | chebi:29806 | |
| ROS | ROS | chebi:26523 | ||
| sulphur | sulphur | sulfur | chebi:26833 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|